Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market - Targeting Q1 2026 for expected clearance of the MODD1 in ...
The father found guilty of the manslaughter of his daughter by withdrawing her life-saving medication told police it is what the eight-year-old wanted and that he was “happy for her”.
Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...